These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 589226)

  • 1. Response of metastatic breast cancer to combination chemotherapy according to site.
    Russell JA; Baker JW; Dady PJ; Ford HT; Gazet JC; McKinna JC; Nash AG; Powles TJ
    Br Med J; 1977 Nov; 2(6099):1390-1. PubMed ID: 589226
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.
    Frederiksen PL; Joergensen ST; Roesdahl K; Thomsen J; Mouridsen HT
    Cancer Treat Rep; 1978 Mar; 62(3):449-50. PubMed ID: 348314
    [No Abstract]   [Full Text] [Related]  

  • 3. A pilot study of sequential combination chemotherapy with adriamycin and cyclophosphamide, and methotrexate, 5-fluorouracil and prednisolone in advanced breast cancer.
    Collis CH
    Br J Clin Pract; 1978 May; 32(5):139-44. PubMed ID: 666968
    [No Abstract]   [Full Text] [Related]  

  • 4. Moderately high-dosage methotrexate medication in metastatic breast cancer.
    Wils JA
    Neth J Med; 1980; 23(2):59-61. PubMed ID: 7374869
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemotherapy of inoperable breast cancer with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisolone].
    Raevskiĭ IG
    Sov Med; 1976 Aug; (8):112-4. PubMed ID: 1006408
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy of breast cancer.
    Mitchell MS
    Conn Med; 1975 Jan; 39(1):4-5. PubMed ID: 1109851
    [No Abstract]   [Full Text] [Related]  

  • 7. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

  • 8. Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer.
    De Lena M; Brambilla C; Morabito A; Bonadonna G
    Cancer; 1975 Apr; 35(4):1108-15. PubMed ID: 1116104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for breast cancer.
    Allegra JC; Lippman ME
    Compr Ther; 1979 Feb; 5(2):13-7. PubMed ID: 428200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAP (cyclophosphamide, adriamycin, platinum) vs CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) combination chemotherapy in untreated metastatic breast cancer. A preliminary report of a controlled clinical study.
    Kolarić K; Roth A; Vukas D; Cervek J
    Cancer Chemother Pharmacol; 1984; 13(2):142-4. PubMed ID: 6380789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined chemotherapy and radiotherapy for locally advanced breast cancer.
    Rubens RD; Sexton S; Tong D; Winter PJ; Knight RK; Hayward JL
    Eur J Cancer (1965); 1980 Mar; 16(3):351-6. PubMed ID: 7371690
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project.
    Smalley RV; Carpenter J; Bartolucci A; Vogel C; Krauss S
    Cancer; 1977 Aug; 40(2):625-32. PubMed ID: 329975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclical combination chemotherapy in advanced breast cancer.
    Edelstyn GA; Marcrae KD
    Ann R Coll Surg Engl; 1974 Jun; 54(6):275-6. PubMed ID: 4833779
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemotherapy of breast cancer].
    Wilmanns W; Hartenstein R; Sauer H; Binsack T
    Gynakol Rundsch; 1981; 21 Suppl 2():9-22. PubMed ID: 7319304
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT; Palshof T
    Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adjuvant chemotherapy in breast cancer].
    Senn HJ
    Dtsch Med Wochenschr; 1981 Nov; 106(48):1626-30. PubMed ID: 7030686
    [No Abstract]   [Full Text] [Related]  

  • 17. Sequence for developing optimal combination chemotherapy of metastatic breast cancer.
    Rosner D; Nemoto T
    Eur J Cancer (1965); 1979 Oct; 15(10):1197-201. PubMed ID: 520394
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy of advanced breast cancer. Results of a controlled trial comparing two three-drug regimens.
    Chauvergne J; Berlie J; Clavel B; Guerrin J; Gary-Bobo J; Brulé G; Klein T; Pommatau E; Carton M
    Eur J Cancer (1965); 1978 Sep; 14(9):911-7. PubMed ID: 361415
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination chemotherapy in disseminated carcinoma of the breast.
    Stutz FH; Blom J; Tormey DC
    Oncology; 1974; 29(2):139-46. PubMed ID: 4525917
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role and limitations of chemotherapy in breast cancer].
    Cattan A; Pourny C
    Sem Hop; 1975 Jul 10-20; 51(31-34):2119-21. PubMed ID: 170687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.